Editorial: NK Cell Subsets in Health and Disease: New Developments.
作者信息
Marcenaro Emanuela, Notarangelo Luigi D, Orange Jordan S, Vivier Eric
机构信息
Department of Experimental Medicine (DIMES), Center of Excellence for Biomedical Research (CEBR), University of Genova, Genova, Italy.
Immune Deficiency Genetics Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
出版信息
Front Immunol. 2017 Oct 18;8:1363. doi: 10.3389/fimmu.2017.01363. eCollection 2017.
Abstract
摘要
相似文献
1
Editorial: NK Cell Subsets in Health and Disease: New Developments.社论：健康与疾病中的自然杀伤细胞亚群：新进展
Front Immunol. 2017 Oct 18;8:1363. doi: 10.3389/fimmu.2017.01363. eCollection 2017.
2
Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.源自体外扩增和激活的脐血单个核细胞的自然杀伤细胞和自然杀伤样T细胞的特性：对过继性细胞免疫治疗的意义
Exp Hematol. 2009 Oct;37(10):1216-29. doi: 10.1016/j.exphem.2009.07.009. Epub 2009 Jul 26.
3
Role of Distinct Natural Killer Cell Subsets in Anticancer Response.不同自然杀伤细胞亚群在抗癌反应中的作用。
Front Immunol. 2017 Mar 16;8:293. doi: 10.3389/fimmu.2017.00293. eCollection 2017.
4
Markers and function of human NK cells in normal and pathological conditions.正常和病理条件下人类自然杀伤细胞的标志物与功能
Cytometry B Clin Cytom. 2017 Mar;92(2):100-114. doi: 10.1002/cyto.b.21508. Epub 2017 Feb 12.
5
[NK cell-based immunotherapy: new prospects and involvement of dendritic cells].[基于自然杀伤细胞的免疫疗法：树突状细胞的新前景与参与情况]
Bull Cancer. 2003 Aug-Sep;90(8-9):699-705.
6
Therapeutic potential and challenges of natural killer cells in treatment of solid tumors.自然杀伤细胞在实体瘤治疗中的治疗潜力与挑战
Front Immunol. 2015 Apr 29;6:202. doi: 10.3389/fimmu.2015.00202. eCollection 2015.
7
[NK cells and innate immunity to malaria].[自然杀伤细胞与疟疾的固有免疫]
Med Sci (Paris). 2006 Aug-Sep;22(8-9):739-44. doi: 10.1051/medsci/20062289739.
8
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.异基因自然杀伤细胞作为癌症免疫治疗平台的兴起：近期创新与未来发展
Front Immunol. 2017 May 31;8:631. doi: 10.3389/fimmu.2017.00631. eCollection 2017.
9
Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.B 细胞慢性淋巴细胞白血病（B-CLL）患者来源的自然杀伤（NK）细胞和自然杀伤样 T（NKT）细胞群体的扩增：细胞免疫治疗的潜在来源。
Leukemia. 2003 Oct;17(10):1973-80. doi: 10.1038/sj.leu.2403083.
10
NK cell subsets and their role in allergy.自然杀伤细胞亚群及其在过敏中的作用。
Expert Opin Biol Ther. 2011 Jul;11(7):833-41. doi: 10.1517/14712598.2011.572549. Epub 2011 Mar 23.
引用本文的文献
1
Machine Learning-Driven Identification of Blood-Based Biomarkers and Therapeutic Agents for Personalized Ischemic Stroke Management.机器学习驱动的基于血液的生物标志物和治疗药物识别，用于个性化缺血性中风管理。
J Cardiovasc Transl Res. 2025 Jul 22. doi: 10.1007/s12265-025-10635-w.
2
Targeting Complex Cutaneous Viral Infections in Search of Inborn Errors of Immunity.针对复杂皮肤病毒感染探寻免疫缺陷病
Acta Derm Venereol. 2025 Jun 9;105:adv41318. doi: 10.2340/actadv.v105.41318.
3
Autoimmunity in thymic epithelial tumors: a not yet clarified pathologic paradigm associated with several unmet clinical needs.胸腺癌中的自身免疫：一个尚未阐明的病理模式，与多个未满足的临床需求相关。
Front Immunol. 2024 Apr 2;15:1288045. doi: 10.3389/fimmu.2024.1288045. eCollection 2024.
4
Natural Killer Cells and Cytotoxic T Cells: Complementary Partners against Microorganisms and Cancer.自然杀伤细胞和细胞毒性T细胞：对抗微生物和癌症的互补伙伴。
Microorganisms. 2024 Jan 22;12(1):230. doi: 10.3390/microorganisms12010230.
5
Identification of a novel cord blood NK cell subpopulation expressing functional programmed death receptor-1.鉴定表达功能性程序性死亡受体-1 的新型脐血 NK 细胞亚群。
Front Immunol. 2023 Jun 22;14:1183215. doi: 10.3389/fimmu.2023.1183215. eCollection 2023.
6
AKT inhibition interferes with the expression of immune checkpoint proteins and increases NK-induced killing of HL60-AML cells.AKT 抑制会干扰免疫检查点蛋白的表达，并增强 NK 诱导的 HL60-AML 细胞杀伤作用。
Einstein (Sao Paulo). 2023 Jun 19;21:eAO0171. doi: 10.31744/einstein_journal/2023AO0171. eCollection 2023.
7
The application of autologous cancer immunotherapies in the age of memory-NK cells.自体癌症免疫疗法在记忆 NK 细胞时代的应用。
Front Immunol. 2023 May 2;14:1167666. doi: 10.3389/fimmu.2023.1167666. eCollection 2023.
8
Immature natural killer cells promote progression of triple-negative breast cancer.未成熟自然杀伤细胞促进三阴性乳腺癌进展。
Sci Transl Med. 2023 Mar 8;15(686):eabl4414. doi: 10.1126/scitranslmed.abl4414.
9
Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cells.芦可替尼并没有完全消除 TLR4/9 配体激活的 NK 细胞的功能能力。
Front Immunol. 2023 Jan 5;13:1045316. doi: 10.3389/fimmu.2022.1045316. eCollection 2022.
10
Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications.自然杀伤细胞在 SARS-CoV-2 感染中的作用：病理生理学及治疗意义。
Front Immunol. 2022 Jun 30;13:888248. doi: 10.3389/fimmu.2022.888248. eCollection 2022.
Zotero 插件